Bioequivalence Study in Healthy Volunteers

Phase 1

Completed

• Conditions: Healthy

• Registration Number: NCT00387985
• Lead Sponsor: Bausch Health Americas, Inc.

Brief Summary

Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-08
• Primary Completion: 2006-09
• Study Completion: 2006-09
• Study First Submitted: 2006-10-11
• Study First Submitted QC: 2006-10-12
• Study First Posted: 2006-10-13
• Status Verified: 2019-11
• Last Update Submitted: 2019-11-21
• Last Update Posted: 2019-11-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
bioequivalence